Close

OraSure Technologies (OSUR) Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

Go back to OraSure Technologies (OSUR) Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization
OraSure Technologies, Inc. (NASDAQ: OSUR) Delayed: 6.14 --0 (-0%)
Previous Close $6.14    52 Week High $9.05 
Open $6.14    52 Week Low $5.10 
Day High $6.14    P/E N/A 
Day Low $6.14    EPS $-0.20 
Volume 94